Baxter Makes $380M Buy; Could HGSI be GSK's Next Target? - Aug. 25, 2011

Having trouble viewing this email? View in Browser.

Thursday, August 25, 2011  |   |   |   |  CHI's 11 Annual PepTalk: The Protein Science WeeK January 9-13, 2012 | Hotel Del Coronado | San Diego, CA www.chi-peptalk.com REGISTER BY FRIDAY, AUGUST 26 and SAVE UP TO $400! PepTalk 2012 continues the tradition of strong scientific programming centered around protein-based therapeutics. The four distinct protein pipelines focused on formulation, purification, biotherapeutics and expression range from applying protein discovery research, to developing downstream protein products that ultimately lead to clinical applications. Create your own agenda by moving between the tracks and choosing the sessions that best fit your research and networking needs. Please click here for more information.   •  Baxter International, Inc. (BAX) Makes $380 Million Buy More... •  Could Human Genome Sciences, Inc. (HGSI) be GlaxoSmithKline (GSK)'s Next Target? More... •  FDA Approves Allergan Inc. (AGN)'s Botox to Treat Specific Form of Urinary Incontinence More... •  FDA: High Doses of Forest Laboratories, Inc. (FRX)'s Celexa Linked to Abnormal Heart Rhythms More... •  Cambridge Spin-out, MISSION Therapeutics Raises $10 Million, Eyes Rapid Growth More... •  Allenex AB Spins off NovaHep and Recopharma AB More... •  ThromboGenics Ltd. (THR.BR) Hopes for Eye Treatment Launch in 2012 More... •  Oxygen Biotherapeutics, Inc. (OXBO) Pushes Out CEO Stern After Internal Probe; CFO Named Interim Chief More... More Top News Gibco® Cell Culture The Difference Between Breakthrough and Try Again Your research will only be as accurate and efficient as your cell culture. That’s why groundbreaking researchers settle for nothing less than Gibco®. It could be the difference between publishing your results and reading someone else’s. See all the Gibco® offers for mammalian cell culture or select from various products via this link. •  Sexist Men and Women - Made for Each Other?, University of Kansas Study More... •  Single Protein, Key to Ebola Virus Infection, Could Aid in Drug Design, Albert Einstein College of Medicine, Whitehead Institute. and Harvard Medical School Study More... •  Experts Find Way to Make Mosquitoes Dengue-Free, Monash University Study More... •  Long-Term Antibiotic Use May Lessen COPD Flare-Ups, University of Colorado Study More... •  Specialized Adult Stem Cells Re-Grow Fingertips, Stanford University Study More... •  Gene Study Sheds New Light On Origins of British Men, University of Oxford and University of Edinburgh Study More... •  Gene Therapy Treats Majority of Children with Rare Immune Disorder, University College London Reveals More... •  Scented Laundry Products Emit Hazardous Chemicals Through Dryer Vents, University of Washington Study More...   More Featured News SafeBridge Consultants, Inc. announces two Potent Compound Safety Training offerings (may be taken separately or consecutively) The SafeBridge original Potent Compound Safety "Boot Camp"® (Boot Camp I) is a comprehensive two-day course in pharmaceutical potent compound safety focused on training EH&S and related professionals in critical technical concepts and proactive safety programs in pharmaceutical industrial hygiene, occupational and environmental toxicology, analytical chemistry, and risk communication. The SafeBridge Advanced Concepts to Support Drug Development of Potent Compounds from R&D through Manufacturing (Boot Camp II) is a one-day advanced course focused on case studies and problem-solving to address potent compound safety issues in discovery, development, contract manufacturing and commercialization. COURSE SEATING IS LIMITED AND USUALLY SELLS OUT! New Brunswick, New Jersey Boot Camp I September 20 - 21, 2011 Boot Camp II September 22, 2011 Contact: Susan Custer at susan.custer@safebridge.com or 650-961-4820 x 231 or www.safebridge.com Clinical Nutrition Pricing and Reimbursement Trends in North America and Europe • Allows clinical nutrition product developers to understand the impact of pricing and reimbursement rates on new products. • Allows marketers to predict how clinical nutrition pricing and reimbursement rates will change over the next several years. • Outlines pricing issues affecting different regions and how these regions compare in terms of clinical nutrition pricing and reimbursement. • Permits readers to understand how pricing and reimbursement trends are shaping clinical nutrition product usage. Click Here for More Information Nature Methods Nature Methods provides techniques for life scientists and chemists. It is a print and online publication dedicated to publishing novel methods together with significant advances to tried and tested techniques allowing researchers to perform faster, better and more efficient experimental research. Request Now! • Biotech Bay (Stanford, California) Stanford University Stanford University Biodesign Innovation Fellowshipt Multidisciplinary teams of four graduate and/or postgraduate engineers, business professionals, bioscientists and physicians collaborate in a process involving clinical immersion, identification and verification of clinical problems, invention, prototyping, early-stage testing, and project planning. • Biotech Bay (Redwood City, California) Astellas Pharma US Senior Manager, US Drug Discovery Finance The position will be primarily responsible for the completion of the monthly closing of each of the entities, preparation of annual budgets, 5-year plans, forecasts, major investment proposals and global corporate initiatives. The successful candidate will lead these organizations to a high level of performance and accountability. • BioTechxus (Austin, Texas) xBiotech USA, Inc. Reserach Associate for Clinical ELISA Perform ELISA using established protocols and written procedures.Assist in development and optimization of immunoassays.Maintain accurate and up to date records of results. • Biotech Beach (San Diego, California) Amylin Pharmaceuticals, Inc. Specialist III, Medical Relations and Info Design, structure, and manage de novo comprehensive product-related standard response letter and standard verbal response Q&A documents; create ad hoc letters for marketed and/or investigational products or disease state. • BioMidwest (Bedford, Ohio) Boehringer Ingelheim Pharmaceuticals, Inc. Master Black Belt, Process Excellence Team Mentor process improvement teams within existing functional and/or cross-functional departments--some projects may be higher in complexity or have very aggressive timelines. Get Noticed! Add your resume to the BioSpace Career Center! See more than 5,000 job postings in the BioSpace Career Center! Biotech Beach Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Biotech Beach Career Fair, San Diego, CA September 22, 2011 • BioMidwest Career Fair, Chicago, IL October 4, 2011 • Pharm Country Career Fair, Bridgewater, NJ October 5, 2011 • Biotech Bay Career Fair, Burlingame, CA October 11, 2011 • Bio NC Career Fair, Durham, NC October 20, 2011 • BioCapital Beach Career Fair, Bethesda, MD November 1, 2011 • Genetown Career Fair, Cambridge, MA November 7, 2011 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services Gilead Sciences, Inc. (Seattle, WA) 2025 1st Avenue, Suite 800 Seattle, Washington 98121 U.S.A. Phone: 206-728-5090 Fax: 206-728-5095 Gilead Sciences, Inc. (Seattle, WA) is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. More Company Profiles FREE Subscription to PharmaVOICE PharmaVOICE delivers the views, opinions, and insights of executives who are shaping the direction of the dynamic life-sciences industry. It provides multiple perspectives on the business challenges, trends, and topics impacting the life-sciences by engaging compelling personalities from diverse industry sectors in a thought-provoking dialog to facilitate and improve business-to-business relationships. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship BioSpace Inc. 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 BioSpace Inc. 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the BioSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Suvarna Sheth, Maysa Darwish, Tammy Liu BioSpace.com - Life. Science. Community. • BioSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 BioSpace http://www.biospace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from Biospace.com e-mail at any time by managing your account here.